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Summary
Objectives: Physical therapies are commonly used for limiting joint inﬂammation. To gain insight into their mechanisms of actions for optimal
usage, we examined persistence of mechanical signals generated by cyclic tensile strain (CTS) in chondrocytes, in vitro. We hypothesized
that mechanical signals induce anti-inﬂammatory and anabolic responses that are sustained over extended periods.
Methods: Articular chondrocytes obtained from rats were subjected to CTS for various time intervals followed by a period of rest, in the pres-
ence of interleukin-1b (IL-1b). The induction for cyclooxygenase (COX-2), inducible nitric oxide synthase (iNOS), matrix metalloproteinase
(MMP)-9, MMP-13 and aggrecan was analyzed by real-time polymerase chain reaction (PCR), Western blot analysis and immunoﬂuorescence.
Results: Exposure of chondrocytes to constant CTS (3% CTS at 0.25 Hz) for 4e24 h blocked more than 90% (P< 0.05) of the IL-1b-induced
transcriptional activation of proinﬂammatory genes, like iNOS, COX-2, MMP-9 and MMP-13, and abrogated inhibition of aggrecan synthesis.
CTS exposure for 4, 8, 12, 16, or 20 h followed by a rest for 20, 16, 12, 8 or 4 h, respectively, revealed that 8 h of CTS optimally blocked
(P< 0.05) IL-1b-induced proinﬂammatory gene induction for ensuing 16 h. However, CTS for 8 h was not sufﬁcient to inhibit iNOS expression
for ensuing 28 or 40 h.
Conclusions: Data suggest that constant application of CTS blocks IL-1b-induced proinﬂammatory genes at transcriptional level. The signals
generated by CTS are sustained after its removal, and their persistence depends upon the length of CTS exposure. Furthermore, the sus-
tained effects of mechanical signals are also reﬂected in their ability to induce aggrecan synthesis. These ﬁndings, once extrapolated to hu-
man chondrocytes, may provide insight in obtaining optimal sustained effects of physical therapies in the management of arthritic joints.
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Cartilage
Repair
SocietyIntroduction
Pathophysiologies associated with joint inﬂammation
impose signiﬁcant impediments to normal joint function1,2.
Because of their notable beneﬁts, patients with arthritic dis-
eases are invariably prescribed rehabilitative therapies for
reducing inﬂammation and to improve joint function3e7.
Duration of treatment for such therapies varies between con-
tinuous passive motion for several days to a few hours per
day of assisted or voluntary joint movements8. However,
no consensus has been achieved whether constant motion
over long periods of time, or precise durations of such ther-
apeutic interventions are required to achieve their optimal
beneﬁts. Despite our increasing understanding of the molec-
ular mechanisms of cartilage development and repair, little is
known about how mechanical signals regulate cartilage re-
pair. For the optimal use of physical therapies to accelerate
cartilage repair it is desirable to understand the mechanisms
of actions of mechanical signals in cartilage repair.
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of cartilage development, homeostasis, and functionali-
ty9e11. As mechanosensitive cells, articular chondrocytes
perceive and respond to mechanical signals throughout
life. Chondrocytes synthesize a unique extracellular matrix
and their integrity, to a large extent, depends upon intracel-
lular signals generated in response to biomechanical
forces2,3,12e15. Chondrocytes maintain a functional balance
between cartilage degradation and repair by production of
various enzymes, cytokines, and matrix associated pro-
teins. A loss of this functional balance is associated with
changes in their phenotypic characteristics which invariably
lead to joint degenerative disorders like osteoarthritis (OA)
and rheumatoid arthritis (RA)16,17.
Phenotypically, articular chondrocytes are characterized
by their ability to synthesize a speciﬁc matrix consisting of
type II collagen and glycosaminoglycans (GAGs) that
allows them to withstand changes in their mechanical
environment. However, this phenotype is pliable and in
response to a pathological insult, is modulated to an inﬂam-
matory phenotype1,18e20. For example, exposure of articu-
lar chondrocytes to an inﬂammatory stimulus leads to their
activation and production of interleukin-1b (IL-1b), tumor
necrosis factor-a (TNF-a), prostaglandin E2 (PGE2), nitric
oxide (NO), and matrix metalloproteinases (MMPs)2,17,21.3
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type and fail to synthesize GAGs and collagen type II.
This inﬂammatory phenotype is responsible for ampliﬁca-
tion of the immune response, cartilage destruction, and pa-
thologies associated with arthritic diseases1,18e20.
The phenotypic characteristics of chondrocytes are also
regulated by biomechanical forces. Both the magnitude
and frequency of biomechanical signals are critical determi-
nants in modulating chondrocytic gene expression21e24.
Biomechanical forces of high (traumatic) magnitudes are
proinﬂammatory and induce enhanced expression of in-
ﬂammatory mediators. Proinﬂammatory alterations in gene
expression lead to enzymatic breakdown of cartilage and
inhibition of matrix synthesis12,24,25. Trauma caused by
mechanical forces of high magnitudes induces rapid
synthesis of proteases involved in GAG and collagen
degradation12,25.
Biomechanical signals of lower magnitudes act as potent
anti-inﬂammatory signals that modulate the inﬂammatory
phenotype to a chondrocytic phenotype by down-regulating
proinﬂammatory gene expression and up-regulating matrix
synthesis15,21e23,27e30. For example, activation of articular
chondrocytes by IL-1b or TNF-a results in a marked upregu-
lation of proinﬂammatory gene induction1,2,17. Signals
generated by mechanical forces of low magnitudes inhibit
IL-1b-induced mRNA transcription and synthesis of potent
catabolic genes like inducible nitric oxide synthase
(iNOS), cyclooxygenase (COX-2), and MMPs. Simulta-
neously, these signals upregulate matrix synthesis by coun-
teracting the proinﬂammatory inhibition of tissue inhibitors of
matrix metalloproteinases (TIMP), GAG synthesis, and col-
lagen II expression13,14,21,22,27e29. In the same context, dy-
namic motion ameliorates the effects of arthritis and
alleviates the pain, by exerting potent anti-inﬂammatory re-
sponses generating reparative signals7,8,14.
Mounting evidence indicates that biomechanical forces
regulate two main categories of genes, those involved
in inﬂammation and those involved in matrix synthe-
sis21,23e25,29,30. Pharmacological therapies like non-
steroidal anti-inﬂammatory drugs suppress the inﬂammatory
response, but are not known to alter the inﬂammatory
phenotype or induce cartilage repair or regeneration. Fur-
thermore, these therapeutics provide transient relief
mostly by inhibiting the cyclooxygenase pathway. In com-
parison, biomechanical signals appear to be more potent
in that they inhibit the induction of a plethora of proinﬂam-
matory genes, as well as upregulate synthesis of matrix
associated molecules13,21,22,28e30. A major consideration
for the efﬁcacious therapeutic use of biomechanical signals
is to know how long the anti-inﬂammatory and reparative
effects are sustained following the removal of the biome-
chanical stimulus. In this report we have examined the
time-dependent consequences of the removal of bio-
mechanical signals on the suppression of proinﬂammatory
gene induction. Our studies show that effects of bio-
mechanical signals are sustained for prolonged periods
of time even in a proinﬂammatory environment.
Materials and methods
ISOLATION OF ARTICULAR CHONDROCYTES
Articular chondrocytes were obtained from the cartilage
of shoulder and knee joints from 14 to 16 weeks old healthy
Sprague Dawley rats (n¼ 5e8)13,21. Approximately 200
microns of superﬁcial cartilage was shaved from the heads
of the bones and ﬁnely chopped. The chondrocytes wereenzymatically released by digestion with 0.2% trypsin
for 15 min, followed by a 3 h digestionwith 0.15%collagenase
I (Worthington Biochemical Corp., NJ) in a two-compartment
digestion chamber kept at 37(C. Chondrocytes were cultured
in Tissue culture medium (TCM) [50% Dulbecco’s modiﬁed
Eagle’s medium and 50% Ham’s F-12 medium (Mediatech,
VA) supplemented with 10% fetal calf serum (FCS) and
penicillin/streptomycin (100 U/100 mg/ml)] at 37(C, in an
atmosphere of 5% CO2 for 7 days. Subsequently, chondro-
cytes (105/well) were transferred to collagen-I coated six-
well Bioﬂex plates (Flexcell International, NC), and grown for
5 days to attain 75e80% conﬂuence. Chondrocytes from
the shoulder and knee were found to respond to mechanical
signals in an identical manner, and therefore were pooled
for these studies. Chondrocytes in passages 2 and 3 were
used for experimentation, where they exhibited typical pheno-
typic markers, i.e., aggrecan, type II collagen, and sox-9
expression13,31.
APPLICATION AND EXPOSURE OF CELLS TO CYCLIC TENSILE
STRAIN (CTS)
Chondrocytes (5 104 cells/well) were cultured in type I
collagen coated, six-well Bioﬂex-II plates (Flexcell Interna-
tional, NC) for 5 to 6 days. Twenty four hours prior to initiat-
ing experiments, TCM of the 80e90% conﬂuent monolayers
of chondrocytes was replaced with TCM containing 1%
FCS as described earlier13. The cells were subjected to
equibiaxial tensile strain, by placing Bioﬂex-II plates on
a loading platform equipped with round loading posts in
a FX-4000T Flexercell Tension System (Flexcell Interna-
tional, NC). Initially, cells were subjected to CTS of various
magnitudes and frequencies in the presence or absence of
recombinant human interleukin-b (IL-1b). CTS at a magni-
tude of 3% and a frequency of 0.25 Hz, suppressed greater
than 90% of the rhIL-1b-induced iNOS mRNA expression
and NO production, reproducibly. Concurrently, cells were
subjected to (1) no treatment (control), (2) rHuIL-1b (1 ng/
ml; Calbiochem, CA), (3) CTS at a magnitude of 3% at
0.25 Hz, or (4) CTS and rHuIL-1b. Cells in groups 3 and 4
were subjected to CTS at the start of the experiment, and
rHuIL-1b was immediately added to groups 2 and 4. Cells
were subjected to CTS for various time intervals, harvested,
and analyzed as required. No differences in the proliferation
rate and cell viability after stretching were observed during
24 h of experimentation.
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION
(RT-PCR)
RNA was isolated from cells using the RNeasy kit
(Qiagen, CA) after shredding through a Qiashredder
(Qiagen, CA). The RNA was subjected to DNAse digestion,
and stored in 40 ml of RNAse-free water. The concentration
and purity of RNA were spectrophotometrically assessed at
260 nm. The abundance of mRNA encoding for aggrecan
was examined as described earlier13,21. A total of 1 mg of
RNA was mixed with 1 mg oligo-dT (12e18 oligomers) in
RT buffer and incubated for 10 min at room temperature.
This mixture was transcribed with 200 units of MULV
reverse transcriptase for 30 min at 37(C. The cDNA was
ampliﬁed with 0.1 mg of speciﬁc primers in a reaction mix-
ture containing 200 mM dNTP and 0.1 units of Taq polymer-
ase in PCR buffer. The three steps of PCR-denaturation,
ampliﬁcation, and extension were done in a thermal cycler
(Eppendorf) for 30 cycles of 40 s at 94(C, 40 s at 62(C and
60 s at 72(C. Each sample that underwent RTwas assessed
1025Osteoarthritis and Cartilage Vol. 14, No. 10for glyceraldehyde phosphate dehydrogenase (GAPDH) as
a standard. The sense and antisense sequences of rat
primers used were as follows: GAPDH (323 bp) sense
50-AGACAGCCGCATCTTCTTGT-30, antisense 50-TACT-
CAGCACCAGCATCACC-30; aggrecan (179 bp) sense 50-
CTACGACGCCATCTGCTACA-30, antisense 50-GCT TTG
CAGTGAGGATCACA-30. PCR products were separated on
a 2%-agarose gel at 100 V/cm in Triseacetate/ethylenedia-
minotetraacetic acid (EDTA) electrophoresis buffer. The
gels were stained with ethidium bromide and then photo-
graphed in Kodak Image Station 440 CF. The intensity of
the bands was analyzed by IMAGE J (NIH, MD) program.
REAL-TIME REVERSE TRANSCRIPTASE-POLYMERASE CHAIN
REACTION
Gene speciﬁc primer sequences were selected using the
TaqMan Probe and Primer Design function of the Primer
Express v1.5 software (Applied Biosystems, CA). The
sense and antisense sequences of rat primers used were
as follows: MMP-13 sense 50-GTTCAAGGAATCCAGTCTC
TCTATGG-30, antisense 50-TGGGTCACACTTCTCTG-GT
GTTT-30, probe 6-FAMd (CCAAGGAGATGAAGACCC
CAACCCTAAGC) BHQ-1 (XM343345); iNOS sense 50-TTC
TGTGCTAATGCGGAAGGT-30, antisense 50-GCTTCCGA
CTTTCCTGTCTCA-30, probe 6-FAMd (CCGCGTCAGAG-
CCACAGTCCT) BHQ-1 (D44591); Cox-2 sense 50-CTT
TGGCAGGCTGGATTTTAA-30, antisense 50-AGAAGCC
CACTGATACCTTTTGC-30, probe 6-FAMd (TGCACAG
TATGACACAACAGCCCATCTCTC) BHQ-1 (AF233596);
MMP-9 sense 50-AGCG-CCAGCCGACTTATGT-30, anti-
sense 50-ACACAGCTGGCAGAGGATTACC-30, probe 6-
FAMd (TCTTCCCCCAGACCTGAAAACCTCC) BHQ-1
(NM_031055). Reverse transcription reactions were carried
out using 2 mg RNA and TaqMan Reverse Transcription re-
agents, followed by real-time PCR using TaqMan PCR
Master Mix and ABI Prism 7700 Sequence Detection Sys-
tem (Applied Biosystems, CA). Reactions were performed
as follows: Cycle I (1): 95(C for 3.0 min, Cycle II (50):
Step 1 at 95(C for 0.3 min, followed by Step 2 at 55(C
for 0.3 min, and Step 3 at 72(C for 30 min, and Cycle III
at 40(C hold. Following ampliﬁcation, a melting curve was
obtained to ensure that primer-dimers or non-speciﬁc prod-
ucts had been eliminated or minimized. The data, obtained
by real-time PCR, were analyzed by the comparative
threshold cycle (CT) method. In this method, the amount
of the target, normalized to GAPDH, and relative to a cali-
brator (either untreated sample or IL-1b-stimulated cells),
is given by 2DDCT , where DDCT¼DCT (sample)DCT
(calibrator), and DCT is the CT of the target gene subtracted
from the CT of GAPDH
27.
CELLULAR PROTEIN ANALYSIS
After exposure to various treatment regimens, Flexcell
membranes from each well were removed and cut into
four to six pie shaped pieces. The cells growing on the Bio-
ﬂex membranes directly over the loading posts of the Flex-
cell plate were analyzed, while the marginal area of the well
stretched by vacuum was excluded. The cellular expression
of proteins was analyzed by immunoﬂuorescence staining,
using mouse anti-iNOS IgG (BD Bioscience 610431) and
FITC conjugated donkey anti-mouse IgG (Jackson
Lab715095151); rabbit anti-COX-2 (Cayman Chemicals,
MI) and goat anti-rabbit-CY3; goat anti-MMP-9 (Santa
Cruz, CA) IgG and donkey anti-goat-FITC (Jackson Lab,
MN). Subsequently, cells were mounted on the membranewith Vectashield (Vector Labs, CA), and observed under
an epiﬂuoresence microscope (Ziess Axioimage) or by laser
scanning cytometry (LSC). At least three membranes from
separate experiments were analyzed. On each membrane,
8 to 10 areas of 50 cells each were counted to assess the
number of ﬂuorescence positive cells by LSC or intensity of
ﬂuorescence by Zeiss Axiovision software (Carl Zeiss Inc.,
Germany).
For GAG analysis sections of the Flexcell membranes ex-
posed to various treatment regimens were ﬁxed with ice
cold methanol and stained with 0.1% Safranin-O for
10 min, and washed gently with water. Subsequently, syn-
thesis of GAGs in chondrocytes and pericellular area was
examined microscopically and analyzed semiquantitatively
using the Zeiss Axiovision software (Carl Zeiss Inc., Ger-
many). The Field Density Means were obtained from ﬁve
different areas of each section of the membrane containing
80 to 100 chondrocytes. The mean values were calculated
and presented as Field Density Means per 100 cells to ob-
tain a comparative value for GAG production in the chon-
drocytes following various treatments.
WESTERN BLOT ANALYSIS
For semiquantitative measurements of proteins synthesis
Western blot analysis was used as described earlier21,27.
Brieﬂy, cells were lysed in ice cold Tris buffered saline
(TBS) containing protease inhibitor cocktail (Roche, IN),
and the extracted proteins were loaded on the sodium do-
decyl sulphate (SDS)-10% acrylamide gels. The proteins
were electrophoretically transferred to nitrocellulose mem-
branes (Bio-Rad, CA) and identiﬁed by monoclonal mouse
anti-MMP-13 IgG (1:1000 dilution; Calbiochem, CA). Mono-
clonal mouse anti-b-actin IgG (1:20,000; Abcam, MA) was
used to reprobe the same blots to equilibrate protein input
in all lanes. Horseradish peroxidase (HRP)-labeled donkey
anti-mouse IgG (1:10,000 dilution; Chemicon, CA) or HRP-
labeled goat anti-rabbit antibody (1:10,000 dilution; Santa
Cruz, CA) was used as a second antibody. The presence
of HRP was detected by Luminol (Amersham, IL), and the
semiquantitative analysis of luminescent bands was carried
out with Kodak Image Station 1000, and Kodak 1D image
analysis software.
DATA ANALYSIS AND STATISTICS
The SPSS 13.0 software (SPSS Inc., Chicago, IL) was
used for statistical analysis. Each experiment was per-
formed at least three times. For quantitative analysis, mean-
s S.E.M. were calculated. To determine whether signiﬁcant
differences exist between groups, One-Way Analysis of
Variance (ANOVA) and the post-hoc multiple comparison
Tukey test were applied. To identify differences between
IL-1b-treated cells in the absence or presence of CTS at
various magnitudes and frequencies, One-Way ANOVA
and the post-hoc multiple comparison Dunnett test were
used. Differences were regarded as statistically signiﬁcant
at values of P< 0.05.
Results
INHIBITION OF IL-1b DEPENDENT INOS INDUCTION BY CTS IS
LONG-LASTING
To gain insight into the effects of biomechanical stimula-
tion that results in sustained anti-inﬂammatory effects, we
ﬁrst determined IL-1b-induced iNOS mRNA expression in
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intervals. As shown in Fig. 1(A) inset, IL-1b induced
a marked upregulation of iNOS mRNA in chondrocytes. Si-
multaneous exposure of cells to CTS for 4, 8, or 16 h
blocked more than 90% of IL-1b-induced iNOS expression
at all time points tested. To further determine how long
the signals generated by CTS persisted, chondrocytes after
addition of IL-1b were immediately subjected to CTS. After
various time intervals CTS was removed and cells allowed
to rest in IL-1b containing medium (CTS/rest) for additional
periods of time, and analyzed for IL-1b-induced iNOS ex-
pression. Figure 1(A) demonstrates that, cells exposed to
CTS/rest for 4/20, 8/16, 12/12, 16/8, 20/4, or 24/0 h, sup-
pressed IL-1b-induced iNOS expression by 54%, 93%,
90%, 84%, 80%, and 90%, respectively, despite the pres-
ence of IL-1b. This suggested that a 4 h exposure to
CTS, that inhibits 97% of IL-1b-induced iNOS expression
[inset Fig. 1(A)], was not sufﬁcient to inhibit iNOS expres-
sion 20 h later. Nevertheless, maximal inhibition of iNOS
expression was observed following an 8 h CTS exposure
which persisted for 16 h [Fig. 1(A)]. LSC analysis of chon-
drocytes immunostained for iNOS revealed that the tran-
scriptional downregulation of iNOS expression by CTS
was also reﬂected in a signiﬁcant reduction (P< 0.05) in
the number of iNOS positive cells [Fig. 1(B)]. Speciﬁcally,
cells exposed to 8, 12 or 16 h of CTS, followed by 16, 12
or 8 h of rest exhibited lowest iNOS synthesis as compared
to IL-1b-treated controls.To further determine how long the CTS-mediated
suppression of IL-1b actions persists, we next exposed IL-
1b-treated chondrocytes to CTS for 8 h followed by a rest
for the ensuing 16, 28, or 40 h. The results demonstrated
CTS exposure for 8 h caused a 90% inhibition of iNOS
mRNA expression 16 h later, but the same exposure failed
to suppress iNOS mRNA expression 28 or 40 h later
[Fig. 1(C)]. Concomitant measurements of NO release in
the culture supernatants, measured by Griess reaction, re-
vealed that NO production was also inhibited by 64% in
chondrocytes exposed to CTS for 8 h followed by a 16 h
rest [Fig. 1(D)]. However, CTS exposure for 8 h was insuf-
ﬁcient to block IL-1b-induced NO production 28 or 40 h
later. This showed that 8 h of CTS is sufﬁcient to inhibit
proinﬂammatory gene induction for a limited period of
time, beyond which effects of IL-1b become apparent again
[Fig. 1(D)].
SUSTAINED DOWNREGULATION OF COX-2 INDUCTION BY CTS
To conﬁrm that CTS regulates transcriptional activation of
multiple proinﬂammatory genes upregulated in arthritic
joints, we next determined the effects of CTS on COX-2 in-
duction. The extent of the persistence of CTS signals on
COX-2 mRNA expression was evaluated by subjecting
the chondrocytes to CTS and IL-1b as described above.
Quantitative analysis of PCR products showed a low level
constitutive COX-2 mRNA expression in chondrocytes. AsFig. 1. Effect of CTS on iNOS induction in articular chondrocytes. Chondrocytes grown on Bioﬂex plates were exposed to CTS for 0, 4, 8 or
16 h, in the presence of IL-1b (inset A), or CTS followed by rest (CTS/rest) for 4/20, 8/16, 12/12, 16/8, 20/4 or 24/0 h, in the constant presence
of IL-1b (A). The expression of iNOS mRNA was analyzed by real-time PCR (A, and inset A), and iNOS protein was assessed in
immunostained chondrocytes by LSC (B). Analysis of iNOS mRNA expression in chondrocytes exposed to CTS/rest for 8/16, 8/28, or 8/
40 h by real-time PCR (C), and total NO accumulation in the culture supernatants of chondrocytes exposed to CTS/rest for 8/16, 8/28, or
8/40 h (D). Data represent mean and S.E.M. of three separate experiments performed in triplicates. * indicates P< 0.05 as compared to
IL-1b-treated cells.
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20, 8/16, 12/12, 16/8, 20/4, or 24/0 h, signiﬁcantly inhibited
IL-1b induced COX-2 mRNA expression by 37%, 72%,
81%, 88%, and 83%, respectively [Fig. 2(A)]. Nevertheless,
signals generated by CTS which could inhibit 96% of IL-
1b-induced COX-2 mRNA expression [inset Fig. 2(A)] failed
to inhibit more than 37% of COX-2 mRNA expression fol-
lowing a 20 h rest [Fig. 2(A)]. Quantitative analysis by
LSC of cells immunostained for COX-2 revealed that CTS
also inhibits its synthesis in a persistent manner in parallel
to inhibition of COX-2 mRNA [Fig. 2(B)]. Similarly, despite
the presence of IL-1b, signals generated by CTS/rest for
4/20, 8/16, 12/12, 16/8, or 20/4 h blocked COX-2 induction
by a signiﬁcant 68%, 63%, 67%, 76%, or 78%, respectively.
Interestingly, exposure of cells to 24 h of continuous CTS
Fig. 2. Effect of CTS on IL-1b-dependent COX-2 induction in artic-
ular chondrocytes. Chondrocytes grown on Bioﬂex plates, were ex-
posed to CTS for 4 or 24 h, in the presence of IL-1b (inset A), or
CTS/rest for 4/20, 8/16, 12/12, 16/8, 20/4 or 24/0 h, in the constant
presence of IL-1b (A). The expression of COX-2 mRNA was ana-
lyzed by real-time PCR (A, and inset A), and COX-2 protein was as-
sessed in immunostained chondrocytes by LSC (B). Microscopic
representation of chondrocytes treated with CTS/rest for 0/24, 8/
16, 16/8, or 24/0 h in the presence of IL-1b showing nuclear local-
ization of COX-2. Chondrocytes were stained with anti-COX-2 anti-
bodies to show the sustained inhibition of COX-2 synthesis in cells
treated with CTS/rest for various time intervals (C). Data in (A and
B) represent mean and S.E.M. of three separate experiments
performed in triplicates. Micrographs in (C) represent one of
three separate experiments. * indicates P< 0.05 as compared to
IL-1b-treated cells.without rest revealed more than 94% suppression of
COX-2 induction, indicating that constant exposure to
CTS is a persistent suppressor of COX-2 [Fig. 2(B and C)].
As evident in Fig. 2(C), COX-2 induction by IL-1b coin-
cided with its nuclear translocation. Not only did CTS expo-
sure down-regulate IL-1b-induced synthesis of COX-2, but
also its nuclear translocation. Exposure of cells to CTS/
rest for 8/16 to 16/8 h demonstrated a signiﬁcant reduction
in the presence of COX-2 in both the cytoplasmic and
nuclear compartments [Fig. 2(C)]. Interestingly, while a
complete inhibition of COX-2 mRNA expression was not
observed at any time point tested, LSC analysis failed to de-
tect the presence of COX-2 in cytoplasmic or nuclear com-
partment of untreated control chondrocytes.
CTS-MEDIATED SUPPRESSION OF IL-1b-DEPENDENT MMP
INDUCTION
To determine whether continuous application of CTS also
results in the inhibition of IL-1b-inducedMMP-9 andMMP-13
mRNA expression, chondrocytes were exposed to IL-1b
alone for 4 or 24 h. As shown in Fig. 3(A) inset, IL-1b
induced a marked upregulation of MMP-9 and MMP-13
mRNA in chondrocytes. Simultaneous exposure of cells to
CTS for 4 or 24 h blocked more than 90% of IL-1b-induced
MMP-9 and MMP-13 expression. To further determine
whether CTS elicits sustained effects on the inhibition of
MMP-9 and MMP-13 expression, cells were subjected to
CTS/rest for 4/20, 8/16, 12/12, 16/8, 20/4, or 24/0 h, in the
presence of IL-1b. Subsequent mRNA analysis demon-
strated that like iNOS and COX-2, CTS continued to block
both MMP-9 and MMP-13 mRNA expression persistently af-
ter its removal. An 8 h or longer exposure to CTS was re-
quired for its persistent effects. Again, constant application
of CTS for 4 h which inhibited more than 90% of MMP-9
and MMP-13 mRNA expression [inset Fig. 3(A)], exhibited
only a 52% (MMP-9) and 68% (MMP-13) inhibition following
removal of CTS for 20 h, indicating that the signals generated
by CTS persist for a limited time and the IL-1b-induced proin-
ﬂammatory gene expression resumes after removal of CTS.
We further conﬁrmed that CTS-mediated suppression of
IL-1b induction of MMP-9 and MMP-13 mRNA was reﬂected
in sustained inhibition of their synthesis [Fig. 3(B)]. Quanti-
tative analysis of ﬂuorescence by LSC in cells immuno-
stained for MMP-9 and Western blot analysis for MMP-13
revealed that signals generated by CTS also blocked
MMP-9 and MMP-13 synthesis in a sustained manner. As
apparent in Fig. 3(B), protein synthesis in chondrocytes in
response to CTS demonstrated a pattern similar to mRNA
expression for both MMP-9 and MMP-13. Notably, a 4 h
CTS exposure was insufﬁcient to sustain the MMP-9 and
MMP-13 inhibition more than 51% and 69%, respectively
[Fig. 3(B)]. CTS/rest for 8/16 h exhibited maximal inhibition
of both MMP-9 and MMP-13, 16 h later. On the contrary, ex-
amination of protein synthesis after CTS/rest for 12/12, 16/
8, or 20/4 h revealed a suppression of 75%, 66%, or 77%,
respectively, which is signiﬁcantly less than that observed
by CTS/rest for 8/16 h [Fig. 3(B and C)].
CTS-MEDIATED UPREGULATION OF AGGRECAN SYNTHESIS
IS SUSTAINED FOLLOWING REMOVAL OF MECHANICAL
SIGNALS
Since aggrecan constitutes the major protein in the GAGs,
next experiments were designed to examine the effects of
CTS on aggrecan gene transcription. Chondrocytes ex-
pressed high levels of aggrecan mRNA constitutively, and
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were exposed to various durations of CTS or CTS/rest. Chondrocytes exposed to CTS for 4 and 24 h in the presence of IL-1b and analyzed
for MMP-9 and MMP-13 by real-time PCR [inset Fig. 1(A)]. Chondrocytes exposed to CTS/rest for 4/20, 8/16, 12/12, 16/8, 20/4 or 24/0 h were
analyzed by real-time PCR for MMP-9 and MMP-13 mRNA expression (A). Synthesis of MMP-9 was assessed by LSC evaluation of immu-
nostained cells (B and C) and synthesis of MMP-13 was determined by densitometric analysis of Western Blots (B). Data represent mean
and S.E.M. of three separate experiments. * indicates P< 0.05 as compared to IL-1b-treated cells. indicates P< 0.01 as compared to
chondrocytes treated with CTS/rest for 8/16 h.this expression was markedly inhibited (95 4%) by treat-
ment of cells with IL-1b for 4 or 24 h. Simultaneous exposure
of cells to CTS and IL-1b for 4 or 24 h rescued IL-1b-induced
inhibition of aggrecan gene expression by 62% or 41%, re-
spectively [Fig. 4(B)]. To determine whether the signals
generated by CTS persistently upregulate aggrecan gene
transcription, chondrocytes were subjected to the same reg-
imen of CTS/rest as described above. Examination of cells
exposed to CTS/rest for various time intervals, revealed
that CTS consistently revoked IL-1b-dependent inhibition of
aggrecan mRNA expression persistently at all time points
tested, indicating an anti-catabolic role of CTS on chondro-
cytes. For example, a 4.57, 4.62, 5.71, 6.71, 12.28, or 9.57
fold increase in mRNA was observed in cells exposed to
CTS/rest for 4/20, 8/16, 12/12, 16/8, 20/4, or 24/0 h, respec-
tively [Fig. 4(A)]. Thus, cumulatively these data indicated that
CTS exerts potent anabolic effects by mitigating the IL-
1b-mediated inhibition of aggrecan transcriptional regulation.
The semiquantitative analysis of GAG contents in chon-
drocytes revealed a marked inhibition of total GAG contents
in IL-1b-treated cells, as compared to untreated control
cells. Exposure to CTS rescued GAG synthesis by counter-
acting IL-1b-induced GAG inhibition. The effects of CTS
were persistent, and could be observed following removal
of CTS. For example, chondrocytes exposed to CTS/restfor 4/20, 8/16, 12/12, 16/8, 20/4 and 24/0 h in the constant
presence of IL-1b, respectively, exhibited a 245%, 252%,
287%, 330%, 370%, or 265% greater total GAG contents
as compared to IL-1b-treated cells [Fig. 4(C)]. Nevertheless,
GAG synthesis was below untreated control cells unless
cells were treated with CTS/rest for 16/8 or 20/4 h.
Discussion
The present ﬁndings provide molecular basis for the
persistent actions of biomechanical signals in chondro-
cytes. While earlier studies demonstrated that signals
generated by both tensile and compressive forces of low
magnitudes inhibit the IL-1b-dependent proinﬂammatory
gene transcription13,21,22,27e29, the persistence of these
signals in a proinﬂammatory environment is as yet unclear.
Studies directed toward arthritic joint healing in vivo, have
demonstrated that controlled application of biomechanical
stimulation reduces inﬂammation and enhances wound
healing in inﬂamed or injured cartilage7,8,33. However, these
reports do not address the persistence of biomechanical
signals in relation to the duration of motion-based therapies.
To answer such key questions, we have used primary
cultures of chondrocytes to examine the long term effective-
ness of biomechanical strain in attenuating inﬂammatory
1029Osteoarthritis and Cartilage Vol. 14, No. 10Fig. 4. Effect of CTS on IL-1b induced attenuation of aggrecan synthesis. Chondrocytes cultured on Bioﬂex plates were subjected to CTS or
CTS/rest in the presence of IL-1b. Cells exposed to CTS/rest for 4/20, 8/16, 12/12, 16/8, 20/4, or 24/0, were analyzed for GAPDH and ag-
grecan mRNA expression by RT-PCR (inset A), and the intensity of each PCR product measured by densitometric analysis (A). RT-PCR
analysis of chondrocytes exposed to CTS for 0, 4, or 24 h, in the presence of IL-1b (B). GAG synthesis in chondrocytes exposed to
various periods of CTS/rest as shown in (A), was examined by Safranin-O staining, using dichromatic ﬁlter and Axioplan Software. The
bars represent means and S.E.M. of Field Density Mean per 100 cells in ﬁve different areas of membrane, * represents P< 0.05 as compared
to IL-1b-treated cells (C).mediator production and augmenting the extracellular
matrix synthesis in vitro. We show that signals generated
by CTS are sustained for prolonged periods of time follow-
ing the removal of mechanical stimulation, and continue to
act as potent anti-inﬂammatory signals in a proinﬂammatory
environment. We have used CTS at a magnitude of 3%,
which inhibits proinﬂammatory gene induction. Since at
these magnitudes CTS alone does not induce proinﬂam-
matory gene induction, these magnitudes do not appear
to be hyper-physiologic, and hence may be at physiologic
levels.
The examination of the sustained effectiveness of CTS as
an anti-inﬂammatory signal is important to the application of
biomechanical therapies on inﬂamed cartilage. Therefore, to
gain broader understanding of the role of biomechanical sig-
nals in the preservation of cartilage, we have focused on theregulation of four major proinﬂammatory mediators with dis-
tinct functions in cartilage destruction1,9,10,33e35, namely
iNOS, COX-2, MMP-9 and MMP-13. All of these mediators
are produced by chondrocytes and are elevated in arthritic
joints. iNOS and COX-2 are involved in the ampliﬁcation of
proinﬂammatory responses. NO is cytotoxic to chondro-
cytes, damages cartilage, and is involved in the upregulation
of MMPs34,36,37. COX-2 induces prostaglandins that in turn
upregulate production of inﬂammatory mediators including
cytokines to initiate cartilage destruction35,38. Chondrocytes
synthesize a number of MMPs among which MMP-13 and
MMP-9 are major mediators of matrix degradation in RA
and OA12,32. MMP-9 and MMP-13 are directly responsible
for proteolytic degradation of cartilage. In addition to colla-
gen, MMP-13 also degrades the proteoglycans including ag-
grecan, giving it a dual role in matrix destruction. MMP-9 is
1030 S. Madhavan et al.: Biomechanical signals in inﬂammationinvolved in degradation of non-collagen matrix components
of the joints16,33.
The present ﬁndings demonstrate a number of important
points with regard to the biomechanical modulation of articu-
lar chondrocyte phenotype and functions. First, continuous
exposure of chondrocytes to CTS induces a marked sup-
pression of IL-1b-dependent proinﬂammatory gene induc-
tion, during the entire duration of exposure to CTS of low
magnitude (3%) and frequency (0.25 Hz). However, these
studieswere limited to a 24e48 hwindow.Whether the effec-
tiveness of biomechanical signals is reduced after longer
durations is yet to be elucidated. Additionally, exposure of
chondrocytes to continuous CTS from 4 to 24 h inhibits IL-
1b-induced iNOS, COX-2, MMP-9, and MMP-13, mRNA ex-
pression and synthesis, suggesting that the effects of CTS
are not limited to one or two genes, rather its effects are broad
and modulate expression of several proinﬂammatory genes.
The second important point is that the effects of CTS are
persistent and continue to attenuate IL-1b-induced proin-
ﬂammatory gene transcription for hours after the removal
of CTS even in an inﬂammatory environment. CTS-mediated
modulation of proinﬂammatory gene expression is long-
lasting, i.e., if chondrocytes are exposed to CTS for 8 h,
the signals generated by CTS continue to block iNOS
gene transcription and synthesis for the next 16 h. Further-
more, extending the time of exposure to CTS followed by
a shorter interval of rest does not signiﬁcantly alter the
persistence of signals generated by CTS. Additionally, after
removal of CTS the signals continue to suppress multiple
proinﬂammatory genes like COX-2, MMP-9 and MMP-13
in a persistent manner, despite the presence of a proinﬂam-
matory environment. Both of the above observations sug-
gest that the suppression of proinﬂammatory genes
occurs at the transcriptional level. Previously it has been
shown that CTS inhibits IL-1b-induced proinﬂammatory
genes via suppression of nuclear translocation of NF-kB21.
This may explain the CTS-mediated inhibition of multiple
proinﬂammatory genes that are under the control of
NF-kB38. It is also likely that the persistent effects of CTS
in inhibiting proinﬂammatory gene induction are also
controlled by NF-kB transcription factors. If so, whether
this occurs via regulation of NF-kB gene transcription or
regulation of its activation is as yet to be explored.
The third signiﬁcant ﬁnding is that, during biomechanical
modulation of chondrocyte functions, the duration of
exposure to CTS is a critical determinant of the length of
its persistent effects on cells. This is evidenced by the
observations that constant CTS exposure for 4 h leads to
greater than 90% inhibition of iNOS mRNA expression,
whereas, a 4 h CTS exposure followed by a rest of 20 h
results in the re-expression of all proinﬂammatory genes
examined, i.e., iNOS, COX-2, MMP-9 and MMP-13. Simi-
larly, constant CTS exposure for 8 h blocks more than
95% of iNOS gene transcription, and the level of inhibition
of iNOS mRNA expression and synthesis is maintained fol-
lowing a 16 h rest. Nevertheless, an 8 h exposure of CTS
was insufﬁcient to block iNOS gene transcription and NO
production 28 or 40 h later. These ﬁndings suggest that
the extent of persistence of anti-inﬂammatory signals gener-
ated by CTS is dependent upon the duration of exposure of
CTS to the chondrocytes. Additionally, CTS blocks expres-
sion of proinﬂammatory proteins transiently and these
genes re-express following a deﬁned period of rest in
a proinﬂammatory environment. It is important to note that
CTS alone as a constant signal, or after a period of rest,
does not induce proinﬂammatory signals in chondrocytes.
In this regard, the magnitudes of mechanical signals playan important role in inducing or attenuating proinﬂammatory
signals10,12,15,21e30.
LSC analysis in our studies revealed that IL-1b induces
iNOS production in all chondrocytes. However, the re-
expression of iNOS after removal of CTS, varied among
chondrocytes. In cartilage, chondrocytes are shown to be of
different types that differ in their responses to IL-1b39. More-
over, in our studies chondrocytes were obtained from two dif-
ferent sites, shoulder and knee. Therefore, it is feasible that
CTS removal leads to iNOS induction in a certain population
of cells in the presence of a proinﬂammatory stimulus. On the
contrary, LSC analysis demonstrated that CTS blocked
expression of COX-2, MMP-9 and MMP-13 to the same
degree in all cells. Furthermore, re-expression of these pro-
teins following removal of CTS was also similar in all cells.
These ﬁndings again point to the fact that the sustained ef-
fects of CTS in blocking proinﬂammatory gene expression
may be controlled at transcriptional level.
Finally, to be clinically effective as a therapeutic signal in
joint repair, biomechanical signals must exhibit reparative ac-
tions. During biomechanical modulation of chondrocytes, sig-
nals generated by CTS are not only effective in suppressing
proinﬂammatory gene induction, but also in unblocking the
IL-1b-induced inhibition of aggrecan synthesis. The primary
mechanisms for IL-1b-mediated cartilage destruction in-
volve activation of proinﬂammatory genes on one side,
and inhibition of matrix synthesis on the other side7,13.
The above ﬁndings suggest that CTS not only limits the
inﬂammation, but also augments repair of cartilage. For
example, IL-1b-induced blockage of aggrecan mRNA ex-
pression is rapidly abrogated by CTS within 4 h, and these
signals persist following removal of CTS for ensuing 20 h.
Thus, biomechanical signals modulate proinﬂammatory
genes and aggrecan transcription and synthesis in a diamet-
rically opposite manner. These ﬁndings are of interest,
because aggrecan gene expression is controlled by AP-1
transcription factors40, and suggest that signals generated
by CTS may simultaneously act on more than one signaling
cascades to control inﬂammation and initiate repair of in-
ﬂamed chondrocytes.
In conclusion, we have shown that signals generated by
CTS are converted into potent biochemical events that
block the synthesis of catabolic mediators and induce ana-
bolic effects in a persistent manner, long after the removal
of biomechanical stimuli. Within the constraints of these
in vitro observations in a rodent model of chondrocyte acti-
vation, the clear evidence points to the fact that biomechan-
ical forces may indeed induce sustained anabolic
responses in inﬂamed cartilage. It is likely that human chon-
drocytes also respond to mechanical signals in a manner
similar to rat chondrocytes. In such a case, our ﬁndings
serve as a foundation for in vivo studies, and demonstrate
the necessity of using adequate time intervals for sustained
effects of motion-based therapies in the optimal manage-
ment of acute/chronic inﬂammation of the joints.
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